BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
FDA schedules review of NDA for progesterone vaginal gel
Nov. 14, 2011
Scientists at Janssen synthesize new ketohexokinase inhibitors
Nov. 14, 2011
Novel clinical data and analyses presented on Regeneron's rilonacept
Nov. 14, 2011
FDA releases safety communication on Trilipix
Nov. 11, 2011
New cytochrome P450 19A1 inhibitors patented in U.S.
Nov. 11, 2011
Phase II data on FG-4592 presented at Kidney Week
Nov. 11, 2011
Sanofi and Regeneron report on phase II hypercholesterolemia program
Nov. 10, 2011
Unigene discloses topline phase II data on oral parathyroid hormone analogue
Nov. 10, 2011
Merck & Co. launches Nexplanon in U.S.
Nov. 10, 2011
EC grants marketing authorization to orphan drug for adrenal insufficiency in adults
Nov. 9, 2011
Previous
1
2
…
590
591
592
593
594
595
596
597
598
…
1792
1793
Next
RSS